REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
批准号:
nhmrc : GNT1147528
负责人:
A/Pr Andrew Redfern
金额:
$133.37万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cancer cell spread around the body involves changes in the cells which allow them to migrate into blood vessels, travel and then invade other organs, a process called epithelial mesenchymal transition (EMT). EMT also makes cells less sensitive to our best treatments. EMT involves switching on genes that activate these changes and switching off genes that silence them. We will develop therapy that will reverse this process, both reducing cancer spread and making cancer treatment more effective.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REVERSING EPITHELIAL TO MESENCHYMAL TRANSITION BY TARGETED EPIGENETIC EDITING IN BREAST CANCER
-
批准号:nhmrc : 1147528
-
项目类别:Project Grants
-
资助金额:$90.17万
-
财政年份:2018
-
负责人:A/Pr Andrew Redfern
-
依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
-
批准号:nhmrc : GNT1121199
-
项目类别:Project Grants
-
资助金额:$74.87万
-
财政年份:2017
-
负责人:A/Pr Andrew Redfern
-
依托单位:
Activation of BMP4 signalling to inhibit breast cancer metastasis
-
批准号:nhmrc : 1121199
-
项目类别:Project Grants
-
资助金额:$51.15万
-
财政年份:2017
-
负责人:A/Pr Andrew Redfern
-
依托单位:
CHARACTERIZATION OF A NEW SUBTYPE OF AGGRESSIVE BREAST CANCER
-
批准号:nhmrc : GNT1130212
-
项目类别:Project Grants
-
资助金额:$76.32万
-
财政年份:2017
-
负责人:A/Pr Andrew Redfern
-
依托单位:
CHARACTERIZATION OF A NEW SUBTYPE OF AGGRESSIVE BREAST CANCER
-
批准号:nhmrc : 1130212
-
项目类别:Project Grants
-
资助金额:$52.08万
-
财政年份:2017
-
负责人:A/Pr Andrew Redfern
-
依托单位:
Randomised phase II trial of neoadjuvant chemotherapy +/- concurrent aromatase inhibitor endocrine therapy to down-stage large oestrogen receptor positive breast cancer
-
批准号:nhmrc : 1066479
-
项目类别:Project Grants
-
资助金额:$153.53万
-
财政年份:2014
-
负责人:A/Pr Andrew Redfern
-
依托单位:
Testing if the addition of oestrogen lowering treatment to preoperative chemotherapy better reduces the size of large oestrogen receptor positive breast cancer
-
批准号:nhmrc : GNT1066479
-
项目类别:Project Grants
-
资助金额:$218.23万
-
财政年份:2014
-
负责人:A/Pr Andrew Redfern
-
依托单位:
海外基金